Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Impact of HLA Evolutionary Divergence on Clinical Features of Patients with Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

Simona Pagliuca, MD, Carmelo Gurnari, MD, Diego Chowell, PhD, Chirag Krishna, Bhumika J. Patel, MD, Hassan Awada, MD, Cassandra M Kerr, MS, Sunisa Kongkiatkamon, MD, Ashwin Kishtagari, MBBS, Thomas Laframboise, PhD, Yogenthiran Saunthararajah, MD, Babal K. Jha, PhD, Valeria Visconte, PhD, Timothy Chan, MD PhD, Jaroslaw Maciejewski, PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-142693

Published: 2020

Journal Articles

Role of Oligoadenylate Synthetases in Myeloid Neoplasia

Metis Hasipek, PhD, Yihong Guan, PhD, Dale Grabowski, BS, Xiaorong Gu, PhD, Yogenthiran Saunthararajah, MD, Robert Silverman, PhD, George R Stark, PhD, Jaroslaw Maciejewski, PhD, Babal K. Jha, PhD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-142457

Published: 2020

Journal Articles

A Novel Therapeutic Strategy for Preferential Elimination of Multiple Myeloma Cells By Targeting Protein Disulfide Isomerase

Metis Hasipek, PhD, Dale Grabowski, BS, Yihong Guan, PhD, Anand D. Tiwari, PhD, Xiaorong Gu, PhD, Jason Valent, MD, Jaroslaw Maciejewski, PhD, Frederic Joel Reu, James G Phillips, PhD, Babal K. Jha, PhD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-142847

Published: 2020

Journal Articles

Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers

Blood (2020) 136 (6): 698–714.

https://doi.org/10.1182/blood.2019003062

Published: 2020

Includes: Supplemental data

Journal Articles

Functional and Biological Implications of CUX1 Mutations and Deletions in Myeloid Neoplasms

Mai Aly, MD, Zubaidah M Ramdzan', PhD, Yasunobu Nagata, MD PhD, Suresh K. Balasubramanian, MD, Naoko Hosono, MD,PhD, Hideki Makishima, MD,PhD,FACP., Valeria Visconte, PhD, Bartlomiej P. Przychodzen, MSc, Cassandra M. Hirsch, BS, Mikkael A. Sekeres, MD MS, Alain Nepveu", PhD, Jaroslaw Maciejewski", MD,PhD,FACP.

Blood (2017) 130 (Supplement 1): 120.

https://doi.org/10.1182/blood.V130.Suppl_1.120.120

Published: 2017

Journal Articles

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

Blood (2016) 128 (16): 2096–2097.

https://doi.org/10.1182/blood-2016-07-728766

Published: 2016

Journal Articles

Time-dependent changes in mortality and transformation risk in MDS

Blood (2016) 128 (7): 902–910.

https://doi.org/10.1182/blood-2016-02-700054

Published: 2016

Includes: Supplemental data

Journal Articles

An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults

Blood (2015) 125 (12): 1857–1865.

https://doi.org/10.1182/blood-2014-10-607341

Published: 2015

Journal Articles

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Blood (2012) 120 (12): 2454–2465.

https://doi.org/10.1182/blood-2012-03-420489

Published: 2012

Includes: Supplemental data

Journal Articles

Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations

Blood (2012) 120 (10): 2076–2086.

https://doi.org/10.1182/blood-2011-12-399683

Published: 2012

Includes: Supplemental data

Journal Articles

Polycomb segment myeloid malignancies

Yogen Saunthararajah, Jaroslaw Maciejewski

Blood (2012) 119 (5): 1097–1098.

https://doi.org/10.1182/blood-2011-12-391268

Published: 2012

Journal Articles

Disruption of the ASXL1 Gene Is Prevalent In PMF: Analysis of Molecular Genetics and Clinical Phenotypes

Brady L Stein, MD, Donna M Williams, PhD, Michael A McDevitt, MD, PhD, Christine L. O'Keefe, PhD, Ophelia Rogers, Jerry L Spivak, Jaroslaw Maciejewski, Alison R Moliterno, MD

Blood (2010) 116 (21): 3074.

https://doi.org/10.1182/blood.V116.21.3074.3074

Published: 2010

Journal Articles

Efficacy of Rabbit Anti-Thymocyte Globulin (ATG) Compared to Horse ATG In Severe Aplastic Anemia

Manuel Afable, II, Mohammed Shaik, MD, Yuka Sugimoto, MD, PhD, Michael Clemente, Ramon V. Tiu, MD, Sanjay R. Mohan, MD, Nelli Bejanyan, Paul Elson, Matt Kalaycio, MD, Anjali Advani, MD, Ronald Sobecks, MD, Alan E. Lichtin, MD, Mikkael A. Sekeres, MD, MS, Jaroslaw Maciejewski

Blood (2010) 116 (21): 2236.

https://doi.org/10.1182/blood.V116.21.2236.2236

Published: 2010

Journal Articles

Next Generation Exome Sequencing for Identification of the Gene Mutations Associated with Loss of Heterozygozity on Chromosome 7 In Myeloid Malignancies

Yuka Sugimoto, MD, PhD, Hideki Makishima, MD, PhD, Hadrian Szpurka, PhD, MSC, Anna Jankowska, MSC, Kathryn Guinta, Ramon V. Tiu, MD, Christine L. O'Keefe, PhD, Alison R Moliterno, MD, Michael A McDevitt, MD, PhD, Hideki Muramatsu, MD., PhD, Seiji Kojima, MD, PhD, Mehdi Keddache, MSC, Jaroslaw Maciejewski

Blood (2010) 116 (21): 297.

https://doi.org/10.1182/blood.V116.21.297.297

Published: 2010

Journal Articles

Deletions of Xp22.2 Including PIG-A Locus Lead to Paroxysmal Nocturnal Hemoglobinuria.

Christine L. O'Keefe, Chiharu Sugimori, Manuel Afable, Michael Clemente, Kenneth Shain, David Araten, Alan F. List, P.K. Epling-Burnette, Jaroslaw Maciejewski

Blood (2010) 116 (21): 1158.

https://doi.org/10.1182/blood.V116.21.1158.1158

Published: 2010

Journal Articles

Cytogenetic Predictors of Response to Lenalidomide In Myeloid Malignancies without Del(5q)

Yuka Sugimoto, MD, PhD, Mikkael A. Sekeres, MD, MS, Hideki Makishima, MD, PhD, Christine L. O'Keefe, PhD, Kathryn Guinta, Manuel Afable, Kathy Rocha McGraw, BS, Alan F. List, Jaroslaw Maciejewski

Blood (2010) 116 (21): 4016.

https://doi.org/10.1182/blood.V116.21.4016.4016

Published: 2010

Journal Articles

Outcomes In Acute Myeloid Leukemia (AML) Patients Diagnosed with Myeloid Sarcoma with and without Bone Marrow Involvement

Marc Earl, Pharm., D., R.Ph., Alex Fu, Matt Kalaycio, MD, Anjali Advani, MD, Yogen Saunthararajah, MD, Christina Piks, Barb Tripp, Kristy Grimes, Ronald Sobecks, MD, Edward Copelan, MD, Jaroslaw Maciejewski, Mikkael A. Sekeres, MD, MS

Blood (2010) 116 (21): 2165.

https://doi.org/10.1182/blood.V116.21.2165.2165

Published: 2010

Journal Articles

SNP Karyotyping Can Detect Clonality of Stem Cell Compartment and Early Malignant Evolution in Aplastic Anemia

Marcin Wlodarski, Sanjay Mohan, Lukasz Gondek, Jungwon Huh, Michael Clemente, Ramon Tiu, Jaroslaw Maciejewski

Blood (2008) 112 (11): 443.

https://doi.org/10.1182/blood.V112.11.443.443

Published: 2008

Journal Articles

Clonal Hematopoiesis in Philadelphia Chromosome-Negative Bone Marrow Cells of Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors

Ron Paquette, MD, John Nicoll, Meenal Chalukya, Lukasz P Gondek, MD, PhD, Monika Jasek, Charles Sawyers, MD, Neil Shah, MD, PhD, Jaroslaw Maciejewski

Blood (2008) 112 (11): 575.

https://doi.org/10.1182/blood.V112.11.575.575

Published: 2008

Journal Articles

Preliminary Results from a Phase II Trial of Triapine Plus Fludarabine for Adults with Aggressive Myeloproliferative Disorders

Michael A McDevitt, Judith E. Karp, Yun Yen, MD, PhD, Jaroslaw Maciejewski, Igor Espinoza-Delgado

Blood (2008) 112 (11): 2811.

https://doi.org/10.1182/blood.V112.11.2811.2811

Published: 2008

NARROW

Impact of HLA Evolutionary Divergence on Clinical Features of Patients with Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

Role of Oligoadenylate Synthetases in Myeloid Neoplasia

A Novel Therapeutic Strategy for Preferential Elimination of Multiple Myeloma Cells By Targeting Protein Disulfide Isomerase

Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers

Functional and Biological Implications of CUX1 Mutations and Deletions in Myeloid Neoplasms

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

Time-dependent changes in mortality and transformation risk in MDS

An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations

Polycomb segment myeloid malignancies

Disruption of the ASXL1 Gene Is Prevalent In PMF: Analysis of Molecular Genetics and Clinical Phenotypes

Efficacy of Rabbit Anti-Thymocyte Globulin (ATG) Compared to Horse ATG In Severe Aplastic Anemia

Next Generation Exome Sequencing for Identification of the Gene Mutations Associated with Loss of Heterozygozity on Chromosome 7 In Myeloid Malignancies

Deletions of Xp22.2 Including PIG-A Locus Lead to Paroxysmal Nocturnal Hemoglobinuria.

Cytogenetic Predictors of Response to Lenalidomide In Myeloid Malignancies without Del(5q)

Outcomes In Acute Myeloid Leukemia (AML) Patients Diagnosed with Myeloid Sarcoma with and without Bone Marrow Involvement

SNP Karyotyping Can Detect Clonality of Stem Cell Compartment and Early Malignant Evolution in Aplastic Anemia

Clonal Hematopoiesis in Philadelphia Chromosome-Negative Bone Marrow Cells of Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors

Preliminary Results from a Phase II Trial of Triapine Plus Fludarabine for Adults with Aggressive Myeloproliferative Disorders

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only